Actively Recruiting

Age: 18Years +
All Genders
ID04075084

BIO|STREAM.ICM: Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)

Led by Biotronik SE & Co. KG · Updated on 2025-10-01

1400

Participants Needed

31

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the long-term outcomes, performance, and ongoing safety of the BIOMONITOR III and its possible successors in everyday clinical use. It focuses on patients with conditions such as tachycardia, atrial fibrillation, syncope, bradycardia, or cryptogenic stroke. The study is designed as an observational registry, allowing additional scientific investigations with minimal extra effort for participants and study sites. Participants will receive a BIOTRONIK Implantable Cardiac Monitor (ICM) and will use the CardioMessenger device to support the BIOTRONIK Home Monitoring system. The registry monitors patients under routine clinical care without introducing experimental treatments or interventions. Data collection includes the insertion procedure and success rate of the device, as well as the time taken to reach a relevant diagnosis starting from device implantation. Throughout the study, participants will be observed during their regular clinical care visits. Researchers will collect information on device performance, safety, and diagnostic timelines. The study will continue until August 30, 2027, tracking patient outcomes over this extended period. Participation involves consenting to the use of home monitoring technology and agreeing to data collection related to the implanted device and clinical events.

CONDITIONS

Brief Title

Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is intended to receive a BIOTRONIK Implantable Cardiac Monitor (ICM)
  • Patient is able to understand the nature of the registry and to provide written informed consent
  • Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept
Not Eligible

You will not qualify if you...

  • Patient is pregnant or breastfeeding
  • Patient is less than 18 years old
  • Patient is participating in another interventional clinical investigation other than the submodules of BIO|STREAM.ICM

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Day of insertion

Participants receive the BIOTRONIK Implantable Cardiac Monitor device as part of routine clinical care.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants who undergo routine care are observed through the BIOTRONIK Home Monitoring system to track clinical outcomes and device performance.

Ongoing remote monitoring with periodic in-person follow-ups as part of routine care

Trial Site Locations

Total: 31 locations

1

Integral Health

Adelaide, Australia

Actively Recruiting

2

Royal Adelaide Hospital

Adelaide, Australia

Completed

3

Nemocnice Ceske Budejovice, a.s.

České Budějovice, Czechia, 37001

Actively Recruiting

4

Hôpital Saint-André

Bordeaux, France

Completed

5

Le Centre Hospitalier Universitaire de Brest (CHRU Brest)

Brest, France

Actively Recruiting

6

Le Centre Hospitalier Universitaire de Caen (CHRU Caen)

Caen, France

Actively Recruiting

7

Le Centre Hospitalier Universitaire de Tours (CHRU Tours)

Chambray-lès-Tours, France

Active, Not Recruiting

8

Hôpital Gabriel Montpied

Clermont-Ferrand, France

Actively Recruiting

9

Hôpital Haut Lévêque (CHU)

Pessac, France

Actively Recruiting

10

Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Actively Recruiting

11

St. Marienkrankhaus Klinikum Westmünsterland GmbH

Ahaus, Germany

Actively Recruiting

12

Kerckhoff-Klinik GmbH

Bad Nauheim, Germany

Actively Recruiting

13

Rhön-Klinikum

Bad Neustadt an der Saale, Germany

Active, Not Recruiting

14

Universitätsklinik an der Technischen Universität Dresden

Dresden, Germany

Completed

15

Helios Klinikum Erfurt

Erfurt, Germany

Actively Recruiting

16

Klinikum Herford

Herford, Germany

Actively Recruiting

17

Helios Health Institute GmbH

Leipzig, Germany

Actively Recruiting

18

Deutsches Herzzentrum der Charité

Mitte, Germany

Actively Recruiting

19

Klinikum rechts der Isar der Technischen Universität München

München, Germany

Active, Not Recruiting

20

Deutsches Herzzentrum der Charité

Steglitz, Germany

Actively Recruiting

21

Ospedale Civile Ferrari

Castrovillari, Italy

Actively Recruiting

22

Ospedale Maria Vittoria

Torino, Italy

Actively Recruiting

23

Pauls Stradins Clinical University Hospital

Riga, Latvia, 1002

Actively Recruiting

24

Unidade Local de Saúde do Alto Ave, E. P. E.

Guimarães, Portugal

Actively Recruiting

25

Unidade Local de Saúde de Santa Maria, E. P. E.

Lisbon, Portugal

Actively Recruiting

26

Centro Médico Teknon

Erandio, Spain

Actively Recruiting

27

Hospital de Fuenlabrada

Fuenlabrada, Spain

Active, Not Recruiting

28

Hospital Álvaro Cunqueiro

Vigo, Spain

Actively Recruiting

29

Hospital Universitario de Araba

Vitoria-Gasteiz, Spain

Actively Recruiting

30

GZO Spital Wetzikon

Wetzikon, Switzerland

Completed

31

Universitätsspital Zürich (USZ)

Zurich, Switzerland

Actively Recruiting

Loading map...

Research Team

S

Sabrina Hoche, Dr.

D

Dörte Vossmeyer, Dr.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Physiological vs Right Ventricular Pacing Outcome Trial Eval...

Bradycardia

Actively Recruiting

45 locations

320-detector Computed Tomography to Assess Myocardial Extrac...

Atrial Fibrillation

Actively Recruiting

1 location

A Proof of Principle Study of Ondansetron for the Prevention...

Vasovagal Syncope (VVS)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial